• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿的抗生素治疗——全面综述

Antibiotherapy in Children with Cystic Fibrosis-An Extensive Review.

作者信息

Ciuca Ioana Mihaiela, Dediu Mihaela, Popin Diana, Pop Liviu Laurentiu, Tamas Liviu Athos, Pilut Ciprian Nicolae, Almajan Guta Bogdan, Popa Zoran Laurentiu

机构信息

Pediatric Department, University of Medicine and Pharmacy "Victor Babes" Timisoara, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.

Pediatric Pulmonology Unit, Clinical County Hospital Timisoara, Evlia Celebi 1-3, 300226 Timisoara, Romania.

出版信息

Children (Basel). 2022 Aug 20;9(8):1258. doi: 10.3390/children9081258.

DOI:10.3390/children9081258
PMID:36010149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406924/
Abstract

In cystic fibrosis (CF), the respiratory disease is the main factor that influences the outcome and the prognosis of patients, bacterial infections being responsible for severe exacerbations. The etiology is often multi-microbial and with resistant strains. The aim of this paper is to present current existing antibiotherapy solutions for CF-associated infections in order to offer a reliable support for individual, targeted, and specific treatment. The inclusion criteria were studies about antibiotherapy in CF pediatric patients. Studies involving adult patients or those with only in vitro results were excluded. The information sources were all articles published until December 2021, in PubMed and ScienceDirect. A total of 74 studies were included, with a total number of 26,979 patients aged between 0-18 years. We approached each pathogen individual, with their specific treatment, comparing treatment solutions proposed by different studies. Preservation of lung function is the main goal of therapy in CF, because once parenchyma is lost, it cannot be recovered. Early personalized intervention and prevention of infection with reputable germs is of paramount importance, even if is an asymmetrical challenge. This research received no external funding.

摘要

在囊性纤维化(CF)中,呼吸系统疾病是影响患者结局和预后的主要因素,细菌感染是严重病情加重的原因。其病因通常是多微生物的且存在耐药菌株。本文的目的是介绍目前针对CF相关感染的抗菌治疗方案,以便为个体化、靶向性和特异性治疗提供可靠支持。纳入标准为关于CF儿科患者抗菌治疗的研究。排除涉及成年患者或仅有体外结果的研究。信息来源为截至2021年12月在PubMed和ScienceDirect上发表的所有文章。共纳入74项研究,患者总数为26979名,年龄在0至18岁之间。我们针对每种病原体及其特定治疗方法进行了研究,比较了不同研究提出的治疗方案。保留肺功能是CF治疗的主要目标,因为一旦实质组织丧失,就无法恢复。早期个体化干预以及预防感染知名病菌至关重要,即便这是一项不对称的挑战。本研究未接受外部资助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d977/9406924/be7779d0fc40/children-09-01258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d977/9406924/be7779d0fc40/children-09-01258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d977/9406924/be7779d0fc40/children-09-01258-g001.jpg

相似文献

1
Antibiotherapy in Children with Cystic Fibrosis-An Extensive Review.囊性纤维化患儿的抗生素治疗——全面综述
Children (Basel). 2022 Aug 20;9(8):1258. doi: 10.3390/children9081258.
2
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.囊性纤维化合并铜绿假单胞菌感染患者的静脉或口服抗生素治疗:TORPEDO-CF RCT。
Health Technol Assess. 2021 Nov;25(65):1-128. doi: 10.3310/hta25650.
3
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药物敏感性试验
Cochrane Database Syst Rev. 2015 Nov 2(11):CD006961. doi: 10.1002/14651858.CD006961.pub3.
4
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药物敏感性试验
Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD006961. doi: 10.1002/14651858.CD006961.pub4.
5
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药敏试验
Cochrane Database Syst Rev. 2020 May 15;5(5):CD006961. doi: 10.1002/14651858.CD006961.pub5.
6
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.囊性纤维化患者肺部病情加重时针对洋葱伯克霍尔德菌复合群的抗生素治疗
Cochrane Database Syst Rev. 2012 Oct 17;10:CD009529. doi: 10.1002/14651858.CD009529.pub2.
7
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?囊性纤维化患者呼吸道假单胞菌感染的治疗:用什么药物及采用何种方式?
Drugs. 2000 Nov;60(5):1053-64. doi: 10.2165/00003495-200060050-00006.
8
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药物敏感性试验
Cochrane Database Syst Rev. 2008 Jul 16(3):CD006961. doi: 10.1002/14651858.CD006961.pub2.
9
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2013 Dec 23(12):CD009530. doi: 10.1002/14651858.CD009530.pub2.
10
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.用于预防囊性纤维化患者感染铜绿假单胞菌复发的治疗方法。
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD012300. doi: 10.1002/14651858.CD012300.pub2.

引用本文的文献

1
Clinical Disorders in Cystic Fibrosis That Affect Emergency Procedures-A Case Report and Review.影响急诊手术的囊性纤维化临床病症——病例报告及综述
J Clin Med. 2025 May 5;14(9):3187. doi: 10.3390/jcm14093187.
2
"Unraveling the Clot-Miscarriage Nexus: Mechanisms, Management, and Future Directions in Thrombosis-Related Recurrent Pregnancy Loss".解析血栓与流产的关联:血栓相关复发性流产的机制、管理及未来方向
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251339421. doi: 10.1177/10760296251339421. Epub 2025 Apr 29.
3
Anti-infectives in Pediatric Patients with Cystic Fibrosis: A Comprehensive Review of Population Pharmacokinetic Analyses.

本文引用的文献

1
Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against from cystic fibrosis patients.头孢他啶/阿维巴坦、头孢洛扎/他唑巴坦及对照药物对囊性纤维化患者分离菌的抗菌活性。
JAC Antimicrob Resist. 2021 Sep 4;3(3):dlab126. doi: 10.1093/jacamr/dlab126. eCollection 2021 Sep.
2
Genomic Diversity and Antimicrobial Resistance of Haemophilus Colonizing the Airways of Young Children with Cystic Fibrosis.定植于囊性纤维化幼儿气道的嗜血杆菌的基因组多样性与抗菌药物耐药性
mSystems. 2021 Aug 31:e0017821. doi: 10.1128/mSystems.00178-21.
3
Factors Influencing Lung Function in Patients with Cystic Fibrosis in Western Romania.
囊性纤维化儿科患者的抗感染药物:群体药代动力学分析的综合综述
Clin Pharmacokinet. 2025 May;64(5):631-653. doi: 10.1007/s40262-025-01505-4. Epub 2025 Apr 21.
4
Predictive Role of Maternal Laboratory Parameters and Inflammatory Scores in Determining Systemic Inflammatory Response Syndrome in Newborns at Birth.母体实验室参数和炎症评分在确定新生儿出生时全身炎症反应综合征中的预测作用。
J Pers Med. 2024 Jun 22;14(7):672. doi: 10.3390/jpm14070672.
5
Antibiotic Resistance Trends in Uropathogens during the COVID-19 Pandemic in Western Romania: A Cross-Sectional Study.罗马尼亚西部新冠疫情期间尿路病原体的抗生素耐药性趋势:一项横断面研究
Antibiotics (Basel). 2024 May 30;13(6):512. doi: 10.3390/antibiotics13060512.
6
Comparing Relationship Satisfaction and Body-Image-Related Quality of Life in Pregnant Women with Planned and Unplanned Pregnancies.比较计划妊娠和意外妊娠孕妇的关系满意度及与身体意象相关的生活质量
Diseases. 2024 May 22;12(6):109. doi: 10.3390/diseases12060109.
7
Cystic fibrosis management in pediatric population-from clinical features to personalized therapy.儿科人群中的囊性纤维化管理——从临床特征到个性化治疗
Front Pediatr. 2024 May 10;12:1393193. doi: 10.3389/fped.2024.1393193. eCollection 2024.
8
Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.血栓形成倾向相关突变导致早期和晚期妊娠丢失的危险因素。
Medicina (Kaunas). 2024 Mar 22;60(4):521. doi: 10.3390/medicina60040521.
9
Extracellular vesicles secreted by primary human bronchial epithelial cells reduce burden and inflammation in cystic fibrosis mouse lung.原代人支气管上皮细胞分泌的细胞外囊泡可减轻囊性纤维化小鼠肺部的负担和炎症。
Am J Physiol Lung Cell Mol Physiol. 2024 Feb 1;326(2):L164-L174. doi: 10.1152/ajplung.00253.2023. Epub 2023 Dec 12.
10
A case of localized paranasal sinusitis associated with ST 1880 in a cystic fibrosis patient.一名囊性纤维化患者发生与ST 1880相关的局限性鼻窦炎病例。
Heliyon. 2023 May 26;9(6):e16618. doi: 10.1016/j.heliyon.2023.e16618. eCollection 2023 Jun.
罗马尼亚西部囊性纤维化患者肺功能的影响因素
J Multidiscip Healthc. 2021 Jun 15;14:1423-1429. doi: 10.2147/JMDH.S313209. eCollection 2021.
4
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.囊性纤维化中非结核分枝杆菌药物治疗的临床药代动力学和药效学考虑因素。
Clin Pharmacokinet. 2021 Sep;60(9):1081-1102. doi: 10.1007/s40262-021-01010-4. Epub 2021 May 13.
5
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).吸入性氨曲南赖氨酸在囊性纤维化急性肺部加重症治疗中的临床和微生物学应用:一项开放标签随机交叉研究(AZTEC-CF)。
J Cyst Fibros. 2021 Nov;20(6):994-1002. doi: 10.1016/j.jcf.2020.12.012. Epub 2021 Jan 7.
6
Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study.利用治疗药物监测优化囊性纤维化患者慢性嗜麦芽窄食单胞菌肺炎中阿维巴坦/头孢他啶-阿唑巴坦组合中的氨曲南:病例研究。
Ther Drug Monit. 2021 Apr 1;43(2):146-149. doi: 10.1097/FTD.0000000000000857.
7
Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis.影响囊性纤维化患者早期铜绿假单胞菌感染获得和清除的因素。
J Cyst Fibros. 2021 Jan;20(1):8-16. doi: 10.1016/j.jcf.2020.10.008. Epub 2020 Nov 7.
8
Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.研究法国囊性纤维化中心嗜麦芽寡养单胞菌的流行病学。
Respir Med Res. 2020 Nov;78:100757. doi: 10.1016/j.resmer.2020.100757. Epub 2020 Apr 18.
9
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD010004. doi: 10.1002/14651858.CD010004.pub5.
10
Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.吸入型盐酸万古霉素干粉剂(AeroVanc)在健康志愿者和囊性纤维化患者中的安全性和药代动力学的 I 期剂量递增研究:耐甲氧西林金黄色葡萄球菌治疗的新方法。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01776-19.